La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Mesa Air Gr a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Mesa Air Gr..

Mesa Air Gr (NASDAQ:MESA) Azioni, Catena delle Opzioni

Mesa Air Gr

Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.

WallStreet.Banks.Shutterstock

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

ELPW

MESA

MKFG

Il mercato indica un sovrapprezzo per alcuni titoli del settore. Un&#39;analisi basata sull&#39;indicatore RSI rivela le azioni da monitorare.

3 titoli del settore industriale che potreste voler scaricare questo mese

Mesa Air Group Inc

MESA HOME RESOURCES by Mesa Home Resources Inc.

Mesa Home Resources Inc

Mesa Laboratories Inc

Mesa Royalty Trust

Mesabi Trust

Health Care

General

Aspira Women's Health Expects To Start Trading Under Its New Symbol "AWHL" On Markets Operated By The OTC Markets Group Today 17 April, Replacing AWH Ticker

Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) reported quarterly earnings of $0.92 per share which missed the analyst consensus estimate of $0.98 by 6.12 percent. This is a 48.39 percent increase over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $280.48 million which missed the analyst consensus estimate of $284.80 million by 1.52 percent. This is a 9.42 percent increase over sales of $256.33 million the same period last year.

Earnings

Earnings Misses

TCBI

Texas Capital Bancshares Q1 2025 Adj EPS $0.92 Misses $0.98 Estimate, Sales $280.48M Miss $284.80M Estimate

<a href="https://www.reuters.com/business/aerospace-defense/musks-spacex-is-frontrunner-build-trumps-golden-dome-missile-shield-2025-04-17/" title="https://www.reuters.com/business/aerospace-defense/musks-spacex-is-frontrunner-build-trumps-golden-dome-missile-shield-2025-04-17/">https://www.reuters.com/business/aerospace-defense/musks-spacex-is-frontrunner-build-trumps-golden-dome-missile-shield-2025-04-17/</a>

Rumors

Contracts

PLTR

Reuters Reported SpaceX, Palantir Emerge As Frontrunners For Key Role In Trump's Golden Dome Missile Defense Shield

Biotech

Large Cap

Earendil Labs And Sanofi Entered Into A License Agreement For Two Bispecific Antibodies In The Field Of Autoimmune And Inflammatory Bowel Diseases, HXN-1002 and HXN-1003, For An Upfront Payment Of $125M And $1.72B In Milestone Payments

Hooker Furnishings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFT#NASDAQ">HOFT</a>) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $0.16 by 237.5 percent. This is a 466.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $104.46 million which beat the analyst consensus estimate of $101.16 million by 3.26 percent. This is a 7.94 percent increase over sales of $96.78 million the same period last year.

Earnings Beats

HOFT

Hooker Furnishings Q4 EPS $(0.22) Misses $0.16 Estimate, Sales $104.46M Beat $101.16M Estimate

Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) reported quarterly earnings of $0.87 per share which met the analyst consensus estimate. This is a 3.33 percent decrease over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $4.947 billion which beat the analyst consensus estimate of $4.937 billion by 0.20 percent. This is a 1.56 percent increase over sales of $4.871 billion the same period last year.

Truist Finl Q1 2025 Adj. EPS $0.87, Inline, Sales $4.947B Beat $4.937B Estimate

Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.51 by 5.88 percent. This is a 22.73 percent increase over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $1.81 billion which missed the analyst consensus estimate of $1.83 billion by 1.10 percent. This is a 0.67 percent increase over sales of $1.80 billion the same period last year.

Regions Finl Q1 Adj $0.54 Beats $0.51 Estimate, Adj Sales $1.81B Miss $1.83B Estimate

Offerings

Marex Group Priced The Public Offering Of 10.28M Shares By Certain Selling Shareholders At $35.50 Per Share. The Selling Shareholders Have Granted The Underwriters An Option To Purchase Up To An Additional 1.54M Shares

UnitedHealth Group revised its 2025 performance outlook established in December 2024 to net earnings of $24.65 to $25.15 per share and adjusted earnings of $26 to $26.50 per share. This outlook reflects two factors:
<ul>
<li>Heightened care activity indications within UnitedHealthcare's Medicare Advantage businesses, which became visible as the quarter closed, far above the planned 2025 increase which was consistent with the elevated levels in 2024. This activity was most notable within physician and outpatient services.</li>
<li>Unanticipated changes in the profile of Optum Health members impacting planned 2025 reimbursement due to unexpectedly minimal 2024 beneficiary engagement by plans exiting markets. In addition, a greater-than-expected impact to current and new complex patients from the ongoing Medicare funding reductions enacted by the previous administration.</li>
</ul>

Guidance

UnitedHealth Expects 2025 Adjusted EPS Of $26-$26.50 Versus Prior Guidance Of $29.50-$30.00 And Consensus Of $29.73

President Donald Trump's auto tariffs are expected to drive up car insurance and repair costs, <a href="https://www.benzinga.com/general/travel/25/04/44785814/car-insurance-premiums-are-set-to-go-through-the-roof-soon-due-to-trumps-auto-tariffs">affecting even drivers who aren't buying new vehicles</a>. What Happened: Trump&#8217;s&nbsp;25% tariffs on imported vehicles&nbsp;are slated to extend to foreign-made auto parts by May 3. Despite hints of potential leniency from Trump, experts predict that the heightened trade barriers will eventually dent consumers&#8217; pockets, NBC News <a href="https://www.nbcnews.com/data-graphics/trump-tariffs-car-insurance-bill-price-auto-repair-cost-rcna201392?ref=biztoc.com">reported</a> on Wednesday.
Auto insurance costs have been climbing for several years, and a prolonged trade war could push&nbsp;the average annual cost of&nbsp;car insurance up by over&nbsp;$300 by the end of&nbsp;the year, with New York and Florida&nbsp;predicted to experience the steepest increases, according to <a href="https://insurify.com/car-insurance/report/">estimates</a>&nbsp;from Insurify.
The rationale is straightforward: insurance companies will have to shell out&nbsp;more to replace damaged car&nbsp;parts that are subject to&nbsp;tariffs. &#8220;When&nbsp;you get into an accident,&nbsp;your car insurance company is&nbsp;the one that&#8217;s&nbsp;going to be buying those&nbsp;parts to repair your vehicle,&#8221; said&nbsp;Terence Lau, dean of Syracuse&nbsp;University's College of Law.
See Also:&nbsp;<a href="https://www.benzinga.com/25/04/44857599/ford-could-hike-prices-of-its-vehicles-in-the-us-amid-auto-tariff-uncertainty-report">Trump Tariffs Could Force Ford To Hike Prices Of Its Vehicles In The US Days After It Extended Employee Pricing To All Customers</a>
Many vehicles are susceptible&nbsp;to multiple Trump administration tariff&nbsp;policies, impacting not only the auto industry but also&nbsp;levies on steel and aluminum,&nbsp;taxes on chips, and duties on global imports.
Why It Matters: Consumers have been scrambling to <a href="https://www.benzinga.com/25/04/44817399/liberation-day-tariffs-why-some-americans-are-rushing-to-buy-a-car-before-trumps-25-auto-duty-hits">purchase cars before the tariffs instigate price increases</a>. Retail sales figures released by the Commerce Department on Wednesday show a 5.3% surge in&nbsp;sales at motor vehicle and&nbsp;parts dealers from February to March. 
Meanwhile, inventories of used vehicles have declined from 43 to 39 days from March to April, according to Cox Automotive.
The tariffs may put companies like Ford Motor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) at high risk of <a href="https://www.benzinga.com/news/25/04/44806252/trump-tariffs-could-put-ford-gm-at-high-risk-of-negative-ratings-report">receiving negative ratings</a> from ratings agency S&amp;P.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/04/44857599/ford-could-hike-prices-of-its-vehicles-in-the-us-amid-auto-tariff-uncertainty-report">Trump Tariffs Could Force Ford To Hike Prices Of Its Vehicles In The US, Days After It Extended Employee Pricing To All Customers</a></li>
</ul>
Photo courtesy: Brandon Woyshnis / Shutterstock.com

Equities

Tech

TSLA

Not Buying A New Car? You May Still Pay An Extra $300 Due To Trump's Auto Tariffs: Here's More

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) reported quarterly earnings of $7.20 per share which missed the analyst consensus estimate of $7.29 by 1.23 percent. This is a 4.2 percent increase over earnings of $6.91 per share from the same period last year. The company reported quarterly sales of $109.58 billion which missed the analyst consensus estimate of $111.60 billion by 1.82 percent. This is a 9.80 percent increase over sales of $99.80 billion the same period last year.

UnitedHealth Group Q1 2025 Adj EPS $7.20 Misses $7.29 Estimate, Sales $109.58B Miss $111.60B Estimate

A 29-year-old video of Rep. Nancy Pelosi is going viral for echoing a message now at the core of <a href="https://www.benzinga.com/news/global/25/04/44856008/china-dismisses-trumps-tariff-numbers-game-files-wto-complaint-talks-can-only-proceed-based-on-mutual">President Donald Trump's trade policy</a>.
In the 1996 clip, Pelosi criticizes U.S. trade practices with China and calls for measures that are noticeably similar to the very tariffs she now opposes.
What Happened: The clip shows Pelosi delivering a House floor speech, where she urged Congress to tackle China's high tariffs on American goods.
She said that while Chinese imports faced only a 2% U.S. tariff, American exports to China were dealt with an average 35% tariff. "Is that reciprocal?" she asked, calling the trade relationship "a job loser" that created millions of jobs in China while creating far fewer in the U.S.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Viral clip shows Nancy Pelosi supporting tariffs on China in 1996: FULL REMARKS" width="500" height="281" src="https://www.youtube.com/embed/kyMyyenz4gg?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/commodities/25/04/44833903/gold-surges-above-3300-to-record-high-as-us-china-trade-war-escalates-with-245-tariff">Gold Surges Above $3,300 To Record High As US-China Trade War Escalates With 245% Tariff</a>
Why It Matters: The resurfaced video comes as China's total tariffs have <a href="https://www.benzinga.com/markets/25/04/44831287/trump-administration-imposes-up-to-245-tariff-on-chinese-imports-amid-intensifying-trade-battle">reached as high as 245%</a> on specific goods, including a 125% reciprocal duty, an additional 20% connected with the fentanyl crisis, and targeted levies ranging from 7.5% to 100% on specific goods, according to the latest reports from the White House.
Pelosi, who is now opposed to Trump's tariff policies, wrote earlier this month on X: "Trump's reckless tariffs will cause chaos… raise prices… and hurt hardworking American families."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Donald Trump's reckless tariffs will cause chaos in our economy, raise prices for consumers and hurt hardworking American families. This is not a strategy — it's the largest tax hike on the American people in history.
&mdash; Nancy Pelosi (@SpeakerPelosi) <a href="https://twitter.com/SpeakerPelosi/status/1907564743172260255?ref_src=twsrc%5Etfw">April 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Like Pelosi, <a href="https://www.benzinga.com/personal-finance/25/04/44843975/they-dont-give-a-damn-about-you-bernie-sanders-says-if-musk-is-firing-federal-workers-with-a-chainsaw-what-happens-when-ai-comes-for-your-job">Sen. Bernie Sanders</a> also once pushed for protectionist policies in a 2008 Senate speech. In a response statement <a href="https://www.foxnews.com/media/flashback-30-years-ago-nancy-pelosi-demanded-congress-confront-chinese-tariffs-american-goods">to</a> Fox News, his team said that Sanders supports targeted tariffs but warned that Trump's sweeping measures would drive up expenses for consumers.
Read Next:
<ul>
<li><a style="font-weight: bold;" href="https://www.benzinga.com/25/04/44843002/analysts-who-predicted-trump-tariffs-says-were-headed-for-worse-financial-crisis-than-2008-its-probably-too-late">Warren Buffett&#8217;s 2003 Plan To Fix The Trade Deficit Without A War Deserves A Second Look As US-China Tariff War Continues</a></li>
</ul>
Image via Shutterstock

Politics

Global

Nancy Pelosi Called US-China Trade "A Job Loser:" Old Remarks Reemerge Amid Trump Tariff Push

<ul>
<li>FF will continue optimizing its capital structure, with an unwavering commitment not to pursue a reverse stock split unless required to maintain its Nasdaq listing.</li>
<li>FX CEO Max and his core team have arrived in Washington, D.C., driving the FF 91, and will meet with key decision-makers at the White House on Thursday. This is not only a business engagement — it reflects our deeper role as a "U.S.–China EV bridge" in shaping future policy directions.</li>
<li>The FX program is progressing well, and we've entered a sprint for the first vehicle rollout by year-end.</li>
<li>Deep Organizational Reform to Unlock Execution and Growth Potential</li>
<li>On April 24, FF will host an Investor Community and Co-Creation Day in Los Angeles.</li>
</ul>

Stock Split

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

Faraday Future Said It Resolutely Opposes a Reverse Stock Split, Is Committed to Maintaining Nasdaq Listing

Ligand Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGND#NASDAQ">LGND</a>) and Channel Therapeutics Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#NYSE">CHRO</a>) on Thursday signed a definitive merger agreement to combine Ligand&#8217;s wholly owned subsidiaries, Pelthos Therapeutics Inc. and LNHC, Inc. (collectively Pelthos) with CHRO Merger Sub Inc., a wholly <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">owned subsidiary of Channel</a>.
The merger will be supported by $50 million in capital raised from a group of strategic investors led by Murchinson.
Under the merger agreement, Channel will acquire 100% of Pelthos&#8217; issued and outstanding equity interests, change its name to Pelthos Therapeutics, and trade on the NYSE American exchange under the ticker PTHS.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44750854/analyst-sees-big-upside-in-ligands-capital-efficient-biotech-strategy" rel="noreferrer noopener">Analyst Sees Big Upside In Ligand&#8217;s Capital-Efficient Biotech Strategy</a>
In connection with the transaction, Ligand has agreed to invest $18 million in the combined company, and the Investor Group has agreed to invest $32 million in a total of $50 million.
Upon completing the transaction, Scott Plesha, CEO of Pelthos, will become CEO of the combined company, and Frank Knuettel II, CEO of Channel Therapeutics, will become CFO. The transaction is expected to close in the summer of 2025.
The combined company will initially focus on accelerating the commercialization of Pelthos&#8217; Zelsuvmi (berdazimer) topical gel, 10.3%, for Molluscum contagiosum infections in adults and pediatric patients one year and older.
The U.S. Food and Drug Administration (FDA) approved Zelsuvmi in 2024. It is the first and only prescription therapy for molluscum infections approved for use at home by patients, parents, and caregivers.
Ligand is entitled to a 13% royalty on worldwide sales of Zelsuvmi.
The combined company will also retain Channel&#8217;s existing NaV 1.7 development programs for various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks.
In December 2024, Channel Therapeutics announced that it achieved its endpoints in two pre-clinical in vivo models of the company&#8217;s nerve block formulations for acute pain, showing material improvement in efficacy and duration over the existing standard <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42552299/channel-therapeutics-announces-positive-efficacy-data-for-a-depot-formulation-of-a-nav1-7-inhibito" rel="noreferrer noopener">of care, bupivacaine</a>.
An update on the Channel&#8217;s animal efficacy study for its eye pain program will be forthcoming.
&#8220;This transaction presents a compelling opportunity to launch a commercial-ready product, with significant financial backing from Murchinson, that has the potential to deliver both near and long-term value to our shareholders,&#8221; said Todd Davis, CEO of Ligand.
Frank Knuettel II, CEO of Channel Therapeutics, commented, &#8220;We have performed extensive due diligence on the Zelsuvmi market opportunity and their team and operations, and we believe this is an extraordinary opportunity for current Channel shareholders. Strategically, it provides the potential for near-term revenue generation from an FDA-approved drug, the opportunity to advance Channel&#8217;s existing NaV 1.7 programs, and expanded capitalization from strong, long-standing investors.&#8221;
Molluscum contagiosum is a poxvirus and one of the most common skin infections, afflicting an estimated 16.7 million people in the U.S.
Price Action: LGND stock is up 2.08% at $106.80 during the premarket session at the last check Thursday, and CHRO stock closed at $1.26 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44857887/taiwan-semiconductor-q1-surges-41-in-sales-boosted-by-ai-chip-demand-expanded-margins" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor CFO Anticipates Tariffs Impact But Has Not Seen Change In Customer Behavior Yet, Issues Strong Q2 Outlook</a></li>
</ul>

Asset Sales

Market-Moving Exclusives

Exclusives

CHRO

LGND

EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity

EXCLUSIVE: Ligand Pharmaceuticals Tells Benzinga 'Transaction is expected to close in the summer of 2025'

EXCLUSIVE: Ligand Pharmaceuticals Tells Benzinga 'Ligand is entitled to a 13% royalty on worldwide sales of ZELSUVMI'

EXCLUSIVE: Ligand Pharmaceuticals Tells Benzinga 'Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching Pelthos' ZELSUVMI'

EXCLUSIVE: Ligand Pharmaceuticals Tells Benzinga Co's Subsidiary Pelthos Therapeutics Today Announced The Signing Of Definitive Merger Agreement To Combine With Channel Therapeutics

Linus Sebastian, the long-time tech reviewer and founder of Linus Tech Tips, has publicly criticized Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) for its <a href="https://benzinga.com/25/04/44824943/nvidia-makes-next-gen-gaming-cheaper-with-299-graphic-cards">handling of the</a> RTX 5060 Ti launch, calling out the company&#8217;s misleading marketing and uncoordinated review schedule.
What Happened: In the latest LTT video posted on Wednesday, Linus openly expressed his frustration with Nvidia's approach to the RTX 5060 Ti, a mid-range GPU that has garnered significant attention.
&#8220;The game has gotten so stupid that I am just not willing to play it anymore,&#8221; Linus said in the intro of the video.
He pointed to several issues, including Nvidia's overpromising of the card's performance, buggy hardware, and inconsistent software.
The YouTuber criticized Nvidia for cherry-picking data to make the GPU appear more impressive than it is, and for dragging out the launch over several months to keep the product in the news.
See Also: <a href="https://www.benzinga.com/markets/25/04/44857974/jim-cramer-calls-nvidia-a-meme-stock-that-needs-to-be-trimmed-you-cant-own-it-like-you-used-to">Jim Cramer Calls Nvidia A &#8216;Meme Stock&#8217; That Needs To Be Trimmed: &#8216;You Can&#8217;t Own It Like You Used To&#8217;</a>
One of Linus&#8217;s biggest grievances was Nvidia's lack of communication and planning around the review process. LTT alleged that Nvidia failed to provide essential materials such as the review guide and drivers until shortly before the card's official release, leaving creators like Linus with just 3.5 business days to test, retest, and produce content.
This, according to Linus, not only made it difficult to deliver timely, accurate reviews but also contributes to a "crunch culture" that places unnecessary stress on content creators.
Additionally, Linus took issue with Nvidia's bold claim of a 50x performance boost over the GTX 1060 when using Multi-Frame Generation on the RTX 5060 Ti. He pointed out that the GTX 1060, a 2016 model, doesn&#8217;t even support the technology, making this comparison misleading at best.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="I Can't Review GPUs that Don't Exist... RTX 5060 and 5060 Ti" width="500" height="281" src="https://www.youtube.com/embed/Bu8I8fNK9pE?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Nvidia did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga's</a> request for comments.&nbsp;
Why It's Important: Nvidia's GeForce RTX 5060 Ti is available in two versions—16GB for $429 and 8GB for $379—starting April 16. The standard RTX 5060 is set to launch in May for $299.
The RTX 5060 Ti and RTX 5060 graphics cards feature DLSS 4 technologies, including Multi Frame Generation and Super Resolution, delivering smoother gameplay and reduced input latency for a more responsive gaming experience.
These GPUs will be offered by major partners like ASUS, MSI, and GIGABYTE, and featured in prebuilt systems from brands such as ORIGIN PC and MAINGEAR.
Laptops powered by RTX 5060 graphics will start at $1,099 from top manufacturers.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44857317/trump-administration-sees-the-conflict-between-us-chip-goals-and-tariffs-says-nvidia-supplier-asmls-cfo">Trump Administration Sees The Conflict Between US Chip Goals And Tariffs, Says Nvidia-Supplier ASML&#8217;s CFO</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo Courtesy: Piotr Swat on Shutterstock.com

Media

NVDA

Linus Tech Tips Rips Into Nvidia Over RTX 5060 Launch: 'The Game Has Gotten So Stupid That I'm Not Willing To Play It Anymore'

Israel Englander&#8216;s Millennium Management purchased Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) exchange-traded funds in the fourth quarter, according to a February 14 13F-HR filing with the U.S. Securities and Exchange Commission, but these investments have significantly declined in value.
What Happened: The $75 billion hedge fund acquired positions in the Grayscale Bitcoin Mini Trust ETF and the Grayscale Ethereum Mini Trust ETF, which have both suffered substantial losses as of Wednesday.
The firm&#8217;s 768,911 units of the Bitcoin ETF dropped from $43.11 to $37.38 per unit, resulting in a value drop from $33.1 million to $28.7 million – a 13.25% loss of approximately $4.39 million.
The Ethereum investment fared worse, with 1,702,038 units falling from $25.74 to $14.96 per unit. This reduced the total value from $43.8 million to $25.5 million, marking a steep 41.86% decline amounting to roughly $18.34 million.
In total, Millennium's crypto ETF investments have lost an estimated $22.7 million.
See Also: <a href="https://www.benzinga.com/25/04/44857887/taiwan-semiconductor-q1-surges-41-in-sales-boosted-by-ai-chip-demand-expanded-margins">Taiwan Semiconductor CFO Anticipates Tariffs Impact But Has Not Seen Change In Customer Behavior Yet, Issues Strong Q2 Outlook</a>
Why It Matters: These losses come amid broader challenges for Millennium, which reportedly suffered approximately $900 million in losses this year due to market volatility impacting its index rebalancing strategy. Despite these setbacks, the firm was down l<a href="https://www.benzinga.com/markets/25/03/44209624/millennium-management-faces-900m-loss-amid-market-volatility-what-investors-should-know">ess than 1% through February</a>.
Millennium, founded by Englander in 1989 with just $35 million, employs <a href="https://www.benzinga.com/markets/equities/25/01/42807107/israel-englanders-millennium-management-dumps-nvidia-loads-up-on-broadcom-heres-what-the-70-billion-hedge-fund-sees">multiple investment strategies</a> including relative value, equity arbitrage, fixed income, and quantitative approaches.
Englander, who began his career as a floor broker and trader on the American Stock Exchange, has maintained 100% ownership of Millennium since its inception.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44857928/jeff-bezos-sells-seattle-mansion-for-record-63-million-after-move-to-floridas-billionaire-bunker">Jeff Bezos Sells Seattle Mansion For Record $63 Million After Moving To Florida&#8217;s &#8216;Billionaire Bunker&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>
Photo Courtesy: Paopano On Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

ETFs

$BTC

$ETH

AVGO

BABA

Millennium Management's Bitcoin And Ethereum ETFs Purchased In Q4 Suffer $22.7 Million Loss Amid Crypto Slump

Press Releases

Mesa Air Group Announces Increased Utilization from Fourth Calendar Quarter 2024 to First Calendar Quarter 2025

Mesa Air Group Discloses Notice from Nasdaq

Republic Airways and Mesa Air Group to Combine, Creating America's Regional Airline of Choice

MESA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Mesa Air Group, Inc. Is Fair to Shareholders

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DADA, MESA, COOP on Behalf of Shareholders

MESA AIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Mesa Air Group, Inc. - MESA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COOP, MESA on Behalf of Shareholders

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Mesa Air Group, Inc. - MESA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, XAGE, DADA, MESA on Behalf of Shareholders

COOP

DADA

ICAD

OPTN

XAGE

American Airlines Group, Inc. - Common Stock

American Airlines Group

Allegiant Travel

Alaska Air Gr

Azul S.A. American Depositary Shares (each representing three preferred shares)

Azul

Blade Air Mobility, Inc. - Class A Common Stock

Blade Air Mobility

Copa Holdings

Delta Air Lines

flyExclusive

JetBlue Airways Corporation - Common Stock

JetBlue Airways

Joby Aviation

Jet AI

LATAM Airlines Group S.A. American Depositary Shares (each representing two thousand (2,000) shares of Common Stock)

LATAM Airlines Group

Southwest Airlines

Ryanair Holdings plc - American Depositary Shares, each representing five Ordinary Shares

Ryanair Hldgs

SkyWest

Sun Country Airlines Holdings, Inc. - Common Stock

Sun Country Airlines

Volato Group

Surf Air Mobility

United Airlines Holdings, Inc. - Common Stock

United Airlines Holdings

Frontier Group Holdings, Inc. - Common Stock

Frontier Group Holdings

Wheels Up Experience Inc. Class A Common Stock

Wheels Up Experience

Controladora Vuela Compania de Aviacion, S.A.B. de C.V. American Depositary Shares, each representing ten (10) Ordinary Participation Certificates

Comments

Mesa Air Gr

Mesa Air Gr (MESA) Opzioni

Mesa Air Gr (NASDAQ:MESA) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO